Lenalidomide Mylan

Medicinal product

(Invented) name

Lenalidomide Mylan

Active substance (s)

Lenalidomidas

Strength

25 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AX04, Lenalidomide

Marketing authorisation holder

Mylan Pharmaceuticals Limited, Airija

Date of authorisation

2020-12-18

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Capsule, hard	1 vnt.
Lenalidomidas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
105616	91716	1091716	lizdinė plokštelė	N7		Receptinis	EU/1/20/1490/016	Netiekiama	-	-	No	-	-
105617	91717	1091717	lizdinė plokštelė	N21		Receptinis	EU/1/20/1490/017	Netiekiama	-	-	No	-	-
105618	91718	1091718	dalomoji lizdinė plokštelė	N21×1		Receptinis	EU/1/20/1490/018	Netiekiama	-	-	No	-	-
106920	93023	1093023	dalomoji lizdinė plokštelė	N7×1		Receptinis	EU/1/20/1490/026	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-12-18	Registruotas